August 28, 2020
A Delaware federal court on Friday approved a $2 million increase to a patent infringement judgment against Minerva Surgical Inc., saying Hologic Inc. is entitled to roughly $7 million for damages related to infringement of its endometrial ablation treatment NovaSure.
May 02, 2019
Minerva Surgical Inc.'s attempt to revisit a $5 million patent infringement judgment from a Delaware jury failed Thursday when the judge overseeing the case said the jury's decision was supported by evidence presented during a 10-day trial last year.
July 30, 2018
A Delaware federal jury on Friday said Minerva Surgical Inc. should pay Hologic Inc. $4.8 million for infringing a patent covering the endometrial ablation treatment NovaSure, but lessened the blow by finding the infringement wasn't willful.
December 15, 2017
The Patent Trial and Appeal Board on Friday found a Hologic Inc. medical device patent was invalid and rejected a series of proposed substitute claims, following a recent Federal Circuit ruling many believed gave patent owners a better chance at amending patents in America Invents Act reviews.